0001104659-20-135875.txt : 20201215
0001104659-20-135875.hdr.sgml : 20201215
20201215192429
ACCESSION NUMBER: 0001104659-20-135875
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenspan Ira Scott
CENTRAL INDEX KEY: 0001449211
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39788
FILM NUMBER: 201390867
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Scopus BioPharma Inc.
CENTRAL INDEX KEY: 0001772028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821248020
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: (212) 479-2513
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER COMPANY:
FORMER CONFORMED NAME: Scopus Biopharma Inc.
DATE OF NAME CHANGE: 20190327
3
1
tm2038482-2_3.xml
OWNERSHIP DOCUMENT
X0206
3
2020-12-15
0
0001772028
Scopus BioPharma Inc.
SCPS
0001449211
Greenspan Ira Scott
C/O SCOPUS BIOPHARMA INC.
420 LEXINGTON AVENUE, SUITE 300
NEW YORK
NY
10170
1
0
0
0
Common Stock, par value $0.001
80000
D
Common Stock, par value $0.001
1350000
I
HCFP/Capital Partners 18B-1 LLC
Common Stock, par value $0.001
73334
I
HCP/Advest LLC
W Warrant
4.00
2021-10-01
2026-09-30
B Unit
66668
I
HCP/Advest LLC
W Warrant
4.00
2021-10-01
2026-09-30
B Unit
3000000
I
HCFP/Capital Partners 18B-2 LLC
Includes shares held by HCFP/Capital Partners 18B-1 LLC, of which Mr. Greenspan is a member and co-manager, and HCP/Advest LLC, of which Mr. Greenspan is a member and sole manager. Accordingly, he is deemed to have shared voting and dispositive power and sole voting and dispositive power over the shares held by HCFP/Capital Partners 18B-1 LLC and HCP/Advest LLC, respectively. Mr. Greenspan disclaims beneficial ownership of shares held by these entities, except to the extent of his proportionate pecuniary interest therein.
Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027.
Includes securities held by HCFP/Capital Partners 18B-2 LLC, of which Mr. Greenspan is a member and co-manager, and HCP/Advest LLC, of which Mr. Greenspan is a member and sole manager. Accordingly, he is deemed to have shared voting and dispositive power and sole voting and dispositive power over the securities held by HCFP/Capital Partners 18B-2 LLC and HCP/Advest LLC, respectively. Mr. Greenspan disclaims beneficial ownership of securities held by these entities, except to the extent of his proportionate pecuniary interest therein.
/s/ Ira Scott Greenspan
2020-12-15